Aton is a biopharmaceutical company foresees a focused future of medicine.
1998
51
Last FY Revenue $0.7M
Last FY EBITDA -$25K
$13.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Aton achieved revenue of $0.7M and an EBITDA of -$25K.
Aton expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Aton valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $0.7M | XXX | XXX | XXX |
Gross Profit | XXX | $0.6M | XXX | XXX | XXX |
Gross Margin | XXX | 80% | XXX | XXX | XXX |
EBITDA | XXX | -$25K | XXX | XXX | XXX |
EBITDA Margin | XXX | -4% | XXX | XXX | XXX |
EBIT | XXX | -$0.2M | XXX | XXX | XXX |
EBIT Margin | XXX | -28% | XXX | XXX | XXX |
Net Profit | XXX | -$1.2M | XXX | XXX | XXX |
Net Margin | XXX | -179% | XXX | XXX | XXX |
Net Debt | XXX | $3.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Aton's stock price is EUR 0 (or $0).
Aton has current market cap of EUR 7.5M (or $8.4M), and EV of EUR 12.1M (or $13.6M).
See Aton trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$13.6M | $8.4M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Aton has market cap of $8.4M and EV of $13.6M.
Aton's trades at 19.7x EV/Revenue multiple, and -549.6x EV/EBITDA.
Equity research analysts estimate Aton's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Aton's P/E ratio is not available.
See valuation multiples for Aton and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $8.4M | XXX | $8.4M | XXX | XXX | XXX |
EV (current) | $13.6M | XXX | $13.6M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 19.7x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -549.6x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -71.5x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -6.8x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | 431.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAton's revenue per employee in the last FY averaged $14K, while opex per employee averaged $15K for the same period.
Aton's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Aton's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Aton and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -4% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $14K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $15K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 107% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aton acquired XXX companies to date.
Last acquisition by Aton was XXXXXXXX, XXXXX XXXXX XXXXXX . Aton acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Aton founded? | Aton was founded in 1998. |
Where is Aton headquartered? | Aton is headquartered in France. |
How many employees does Aton have? | As of today, Aton has 51 employees. |
Is Aton publicy listed? | Yes, Aton is a public company listed on PAR. |
What is the stock symbol of Aton? | Aton trades under ALTAO ticker. |
When did Aton go public? | Aton went public in 2007. |
Who are competitors of Aton? | Similar companies to Aton include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
What is the current market cap of Aton? | Aton's current market cap is $8.4M |
Is Aton profitable? | Yes, Aton is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.